Ori Biotech is a London- and Philadelphia-based leader in CGT manufacturing technology that has developed a proprietary, bespoke and flexible manufacturing platform, which enables patient access to a new generation of personalized, lifesaving treatments. By fully automating and standardizing CGT manufacturing in a closed platform, Ori offers therapeutics developers the opportunity to seamlessly scale from pre-clinical process development to commercial scale manufacturing. So complex manufacturing challenges can be put where they belong – in the past.
| Website | http://www.oribiotech.com |
| Revenue | $7.8 million |
| Employees | 87 (77 on RocketReach) |
| Founded | 2015 |
| Address | 2 Royal College Street, London, England NW1 0NH, GB |
| Phone | (386) 265-4360 |
| Technologies |
JavaScript
,
HTML
,
PHP
+44 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Pharmaceuticals, Other Healthcare Technology Systems, Cell Therapy, Healthcare, Biotechnology, Cell And Gene Therapy, Cell And Gene Therapy Manufacturing |
| Competitors | Thermo Fisher Scientific, Miltenyi Biotec, Beckman Coulter Life Sciences, Zymeworks Inc., Fate Therapeutics Inc, Spark Therapeutics, Inc., Cellares, GRAIL, SOPHiA GENETICS, CELLINK +42 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies, SIC Code 80 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Ori Biotech employee's phone or email?
The Ori Biotech annual revenue was $7.8 million in 2026.
Jason Foster is the Chief Executive Officer and Executive Director of Ori Biotech.
77 people are employed at Ori Biotech.
Ori Biotech is based in London, England.
The NAICS codes for Ori Biotech are [325, 3254, 32].
The SIC codes for Ori Biotech are [283, 28, 80].